208 related articles for article (PubMed ID: 31395855)
21. Ursolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer.
Shan J; Xuan Y; Zhang Q; Zhu C; Liu Z; Zhang S
Protein Cell; 2016 Aug; 7(8):571-85. PubMed ID: 27472952
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
Nukatsuka M; Nakagawa F; Takechi T
Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
[TBL] [Abstract][Full Text] [Related]
23. Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis.
Yamaguchi Y; Kasukabe T; Kumakura S
Int J Oncol; 2018 Mar; 52(3):1011-1022. PubMed ID: 29393418
[TBL] [Abstract][Full Text] [Related]
24. Perifosine sensitizes curcumin-induced anti-colorectal cancer effects by targeting multiple signaling pathways both in vivo and in vitro.
Chen MB; Wu XY; Tao GQ; Liu CY; Chen J; Wang LQ; Lu PH
Int J Cancer; 2012 Dec; 131(11):2487-98. PubMed ID: 22438101
[TBL] [Abstract][Full Text] [Related]
25. Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems.
Wang H; Jiang H; Corbet C; de Mey S; Law K; Gevaert T; Feron O; De Ridder M
Cancer Lett; 2019 May; 450():42-52. PubMed ID: 30790679
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of PGE
Huang H; Aladelokun O; Ideta T; Giardina C; Ellis LM; Rosenberg DW
Sci Rep; 2019 Mar; 9(1):4954. PubMed ID: 30894570
[TBL] [Abstract][Full Text] [Related]
27. Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways.
Xiong XX; Liu JM; Qiu XY; Pan F; Yu SB; Chen XQ
Acta Pharmacol Sin; 2015 Mar; 36(3):362-74. PubMed ID: 25619389
[TBL] [Abstract][Full Text] [Related]
28. Melatonin Promotes Apoptosis of Oxaliplatin-resistant Colorectal Cancer Cells Through Inhibition of Cellular Prion Protein.
Lee JH; Yoon YM; Han YS; Yun CW; Lee SH
Anticancer Res; 2018 Apr; 38(4):1993-2000. PubMed ID: 29599315
[TBL] [Abstract][Full Text] [Related]
29. Redox-sensitive cyclophilin A elicits chemoresistance through realigning cellular oxidative status in colorectal cancer.
Peng L; Jiang J; Chen HN; Zhou L; Huang Z; Qin S; Jin P; Luo M; Li B; Shi J; Xie N; Deng LW; Liou YC; Nice EC; Huang C; Wei Y
Cell Rep; 2021 Nov; 37(9):110069. PubMed ID: 34852234
[TBL] [Abstract][Full Text] [Related]
30. Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression.
Wang W; Guo W; Li L; Fu Z; Liu W; Gao J; Shu Y; Xu Q; Sun Y; Gu Y
Biochem Pharmacol; 2016 Dec; 121():8-17. PubMed ID: 27693317
[TBL] [Abstract][Full Text] [Related]
31. Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1α/JNK.
Zhao Q; Zhong J; Bi Y; Liu Y; Liu Y; Guo J; Pan L; Tan Y; Yu X
Phytomedicine; 2020 Nov; 78():153306. PubMed ID: 32854039
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
[TBL] [Abstract][Full Text] [Related]
33. Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.
Mei L; Chen Y; Wang Z; Wang J; Wan J; Yu C; Liu X; Li W
Br J Pharmacol; 2015 May; 172(9):2232-45. PubMed ID: 25521075
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells.
Fiore D; Proto MC; Pisanti S; Picardi P; Pagano Zottola AC; Butini S; Gemma S; Casagni A; Laezza C; Vitale M; Ligresti A; Di Marzo V; Zisterer DM; Nathwani S; Williams DC; Campiani G; Gazzerro P; Bifulco M
Cancer Biol Ther; 2016 Aug; 17(8):849-58. PubMed ID: 26392056
[TBL] [Abstract][Full Text] [Related]
35. Endoplasmic reticulum-targeting photosensitizer Hypericin confers chemo-sensitization towards oxaliplatin through inducing pro-death autophagy.
Lin S; Yang L; Shi H; Du W; Qi Y; Qiu C; Liang X; Shi W; Liu J
Int J Biochem Cell Biol; 2017 Jun; 87():54-68. PubMed ID: 28392376
[TBL] [Abstract][Full Text] [Related]
36. AMPKα1 confers survival advantage of colorectal cancer cells under metabolic stress by promoting redox balance through the regulation of glutathione reductase phosphorylation.
Wang YN; Lu YX; Liu J; Jin Y; Bi HC; Zhao Q; Liu ZX; Li YQ; Hu JJ; Sheng H; Jiang YM; Zhang C; Tian F; Chen Y; Pan ZZ; Chen G; Zeng ZL; Liu KY; Ogasawara M; Yun JP; Ju HQ; Feng JX; Xie D; Gao S; Jia WH; Kopetz S; Xu RH; Wang F
Oncogene; 2020 Jan; 39(3):637-650. PubMed ID: 31530934
[TBL] [Abstract][Full Text] [Related]
37. Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer.
Chen ZH; Qi JJ; Wu QN; Lu JH; Liu ZX; Wang Y; Hu PS; Li T; Lin JF; Wu XY; Miao L; Zeng ZL; Xie D; Ju HQ; Xu RH; Wang F
J Exp Clin Cancer Res; 2019 May; 38(1):196. PubMed ID: 31088567
[TBL] [Abstract][Full Text] [Related]
38. Scoulerine promotes cell viability reduction and apoptosis by activating ROS-dependent endoplasmic reticulum stress in colorectal cancer cells.
Tian J; Mo J; Xu L; Zhang R; Qiao Y; Liu B; Jiang L; Ma S; Shi G
Chem Biol Interact; 2020 Aug; 327():109184. PubMed ID: 32590070
[TBL] [Abstract][Full Text] [Related]
39. Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells.
Yu Y; Wu T; Zhang X; Li P; Ye L; Kuang J; Tao L; Ni L; Zhao Q; Zhang J; Pan H; Xie C; Zheng C; Li S; Cui R
Eur J Pharmacol; 2023 Oct; 957():175986. PubMed ID: 37598924
[TBL] [Abstract][Full Text] [Related]
40. Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells.
Li X; Zhu F; Jiang J; Sun C; Wang X; Shen M; Tian R; Shi C; Xu M; Peng F; Guo X; Wang M; Qin R
Cancer Lett; 2015 Feb; 357(1):219-230. PubMed ID: 25444914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
